DRUGS AND REGIMENS

Back to Results >



Rituximab/EPOCH (etoposide, prednisone, – vincristine [Oncovin], doxorubicin, cyclophosphamide) (Non-Hodgkin's lymphoma)

The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)


This Regimen Is Used for:

Recurrent, aggressive disease therapy

Regimen Details

...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Follow OncologySTAT on Twitter

Look for news reports from ASCO and other major conferences, journal scans, and more.
Start following ›

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
    • Forgot your password?
    Not a member? Free registration